What Archon’s antibody cages, or AbCs, do (as documented in this paper published in Science) is offer a scaffold for modifying and multiplying their effectiveness. A free-floating antibody may have only a small chance of binding to a target protein, but if you were to stick a dozen of them together in a big dodecahedron, that significantly and perhaps profoundly improves that chance.

This may be the difference between being able to tell if a medication works or not.